[Therapeutic drug monitoring in epileptology and psychiatry].
Experts from epileptology and psychiatry reviewed the current significance of therapeutic drug monitoring (TDM) of antiepileptic drugs and psychiatric drugs in a workshop at Bethel Epilepsy Centre in December 2005. TDM has been essential in epileptology for about 30 years, and it is also increasingly important in psychiatry, in which consensus recommendations were published recently. With regard to cost-cutting in the health system, there are discussions about the financial effect of TDM and outsourcing it to bigger laboratories. In psychiatry it has however been shown that sensibly used TDM may lead to reduced costs. Many issues in TDM require the knowledge and experience of specialised laboratories. The use of TDM data for scientific purposes was discussed at the workshop as well.
Brandt
C
C
Evangelisches Krankenhaus, Epilepsiezentrum Bethel (Kliniken), Maraweg 21, Bielefeld, Germany. christian.brandt@evkb.de
Baumann
P
P
Eckermann
G
G
Hiemke
C
C
May
T W
TW
Rambeck
B
B
Pohlmann-Eden
B
B
D000927:Anticonvulsants / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics*; D003362:Cost-Benefit Analysis; D004305:Dose-Response Relationship, Drug; D016903:Drug Monitoring / Q000191:economics*; D004359:Drug Therapy, Combination; D004827:Epilepsy / Q000097:blood* / Q000188:drug therapy; D005858:Germany; D006801:Humans; D001523:Mental Disorders / Q000097:blood* / Q000188:drug therapy; D009313:National Health Programs / Q000191:economics*; D011619:Psychotropic Drugs / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics*
D000927:Anticonvulsants; D011619:Psychotropic Drugs
Int J Neuropsychopharmacol. 1999 Mar;2(1):17-23
11281966
Mutat Res. 2001 Oct 1;482(1-2):11-9
11535244
Soc Psychiatry Psychiatr Epidemiol. 1995 Aug;30(5):196-205
7482004
Eur J Clin Pharmacol. 1997;51(6):481-4
9112063
J Pharm Pharmacol. 2004 Aug;56(8):967-75
15285840
Pharmacopsychiatry. 1991 Nov;24(6):190-5
1812496
Clin Pharmacokinet. 2006;45(11):1061-75
17048972
J Clin Psychiatry. 1991 Jun;52 Suppl:23-33
1904862
Am J Psychiatry. 2004 May;161(5):826-35
15121647
Br J Clin Pharmacol. 2006 Feb;61(2):191-9
16433873
Epilepsy Behav. 2003 Oct;4(5):487-95
14527489
Pharmacopsychiatry. 2002 Mar;35(2):50-6
11985287
Epilepsy Res. 2001 Nov;47(1-2):151-4
11673029
Acta Psychiatr Scand. 2001 Sep;104(3):173-92
11531654
Br J Clin Pharmacol. 2002 Feb;53(2):111-22
11851634
Drug Saf. 2006;29(9):735-68
16944962
J Clin Psychopharmacol. 2001 Oct;21(5):500-15
11593076
Ther Drug Monit. 2004 Oct;26(5):582
15385844
Am J Psychiatry. 2002 Jan;159(1):103-8
11772697
Pharmacogenomics. 2002 Mar;3(2):201-18
11972442
Clin Pharmacol Ther. 2004 Jan;75(1):13-33
14749689
Ther Drug Monit. 2006 Feb;28(1):83-8
16418699
Psychopharmacology (Berl). 1982;78(1):25-7
6815692
J Clin Psychopharmacol. 2005 Aug;25(4):342-8
16012277
J Clin Psychiatry. 1999;60 Suppl 1:4-6; discussion 28-30
10037163
Acta Psychiatr Scand. 2000 May;101(5):354-9
10823294
Lancet. 2000 Nov 11;356(9242):1667-71
11089838
Dtsch Med Wochenschr. 1991 Apr 19;116(16):631-3
2015781
Naunyn Schmiedebergs Arch Pharmacol. 2004 Jan;369(1):69-77
14598019
Pharmacopsychiatry. 2004 Nov;37(6):243-65
15551191
Biopharm Drug Dispos. 1999 Nov;20(8):369-77
10870093
J Pharm Biomed Anal. 2004 Sep 3;35(5):1203-12
15336365
Ther Drug Monit. 1999 Apr;21(2):175-81
10217337
J Clin Psychopharmacol. 2001 Jun;21(3):305-10
11386494
Trends Pharmacol Sci. 2004 Aug;25(8):423-9
15276711
Ther Drug Monit. 2004 Apr;26(2):156-60
15228157
Neurology. 2004 Sep 28;63(6):1022-6
15452293
J Clin Psychopharmacol. 2006 Dec;26(6):671-3
17110832